pirimiphos methyl has been researched along with cgp-56697 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aerts, A; Bennett, A; Didier, B; Dufour, MK; Gani, Z; Gosling, R; Greenhouse, B; Hsiang, MS; Katokele, S; Kleinschmidt, I; McCreesh, P; Medzihradsky, OF; Mumbengegwi, D; Ntuku, H; Prach, LM; Roberts, KW; Smith, J; Sturrock, H; Tambo, M; Uusiku, P | 1 |
1 trial(s) available for pirimiphos methyl and cgp-56697
Article | Year |
---|---|
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
Topics: Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Insecticides; Malaria; Male; Mass Drug Administration; Mosquito Control; Mosquito Vectors; Namibia; Organothiophosphorus Compounds; Research Design; Residence Characteristics | 2018 |